|
Rilexine
|
150 mg/ml
|
V/NRP/07/1691
|
Virbac S.A., Francija
|
QJ01DB01
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/07/1691-01 |
150 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/07/1691-02 |
150 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|
|
VeteCorH
|
1000 IU/ml
|
V/DCP/25/0043
|
Laboratorios Calier, S.A., Spānija
|
QG03GA01
|
cattle; pigs; sheep; goats; horses; dogs; cats
|
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0043-01 |
|
1 |
Stikla flakons (kartona kastē); satur liofilizētu granulu, 5000 IU;Stikla flakons (šķīdinātājs kartona kastītē), 5 ml |
-
|
| V/DCP/25/0043-02 |
|
2 |
Stikla flakons (kartona kastē); satur liofilizētu granulu, 5000 IU;Stikla flakons (šķīdinātājs kartona kastītē), 5 ml |
-
|
| V/DCP/25/0043-03 |
|
5 |
Stikla flakons (kartona kastē); satur liofilizētu granulu, 5000 IU;Stikla flakons (šķīdinātājs kartona kastītē), 5 ml |
-
|
| V/DCP/25/0043-04 |
|
1 |
Stikla flakons (liofilizāts), 5000 IU;Stikla flakons (šķīdinātājs stikla flakonā), 5 ml |
-
|
| V/DCP/25/0043-05 |
|
2 |
Stikla flakons (liofilizāts), 5000 IU;Stikla flakons (šķīdinātājs stikla flakonā), 5 ml |
-
|
| V/DCP/25/0043-06 |
|
5 |
Stikla flakons (liofilizāts), 5000 IU;Stikla flakons (šķīdinātājs stikla flakonā), 5 ml |
-
|
|
|
Parofor
|
70000 IU/g
|
V/DCP/14/0058
|
Huvepharma NV, Beļģija
|
QA07AA06
|
pigs; pre-ruminant cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0058-01 |
70 mg/g |
1 |
Papīra/PE/Al folijas/PE paciņa, 1 kg |
-
|
| V/DCP/14/0058-02 |
70 mg/g |
1 |
Papīra/PE/Al folijas/PE paciņa, 250 g |
-
|
| V/DCP/14/0058-03 |
70 mg/g |
1 |
Papīra/PE/Al folijas/PE paciņa, 500 g |
-
|
| V/DCP/14/0058-04 |
70 mg/g |
40 |
PE/AL/PP paciņa, 25 g |
-
|
|
|
Biocatalin
|
-
|
V/NRP/02/1496
|
Fatro S.p.A., Itālija
|
QA11JC
|
cattle; pigs; sheep; horses; dogs; cats; rabbits
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Vitamin B 12,Vitamin B1,Vitamin B2,Vitamin B6,Liver and yeast hydrolysates,Nicotinamide,Pantothenic acid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
13-Jun-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
|
| Summary of product characteristics: |
[DOC] Zāļu_informācija_ZA_M_LI (27-Aug-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1496-01 |
|
1 |
Flakons, 100 ml |
-
|
|
|
Metabolase
|
-
|
V/NRP/01/1378
|
Fatro S.p.A., Itālija
|
QA11JC
|
cattle; pigs; sheep; goats; horses; dogs; cats; rabbits; buffalo
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
L-carnitine hydrochloride, Thiotic acid, Pyridoxine hydrochloride, Cyanocobalamin, D-L Acetylmethionine, L-Arginine, L-ornithine hydrochloride, L-citrulline, L-Lysine hydrochloride, Glycine, Aspartic acid, Glutamic acid, Fructose, Sorbitol
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
04-Jul-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
|
| Summary of product characteristics: |
[DOC] Zāļu_informācija_ZA_M_LI (27-Aug-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1378-01 |
|
1 |
Flakons, 250 ml |
-
|
| V/NRP/01/1378-02 |
|
1 |
Flakons, 500 ml |
-
|
|
|
Canigen CHPPi/LR
|
-
|
V/NRP/00/1234
|
Virbac S.A., Francija
|
QI07AJ06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and suspension for suspension for injection
|
| International name (active substance): |
Inactivated Leptospira icterohaemorrhagiae,Leptospira canicola,Live Canine distemper virus,Live canine parvovirus strain,Live Canine adenovirus type 2 (CAV2), strain Manhattan LPV3,Live canine parainfluenza viruss,Inactivated Rabies suspension
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
09-Jul-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (10-Jan-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/00/1234-01 |
|
1 |
Stikla flakons (plastmasas kastē), 1 deva |
-
|
| V/NRP/00/1234-02 |
|
10 |
Stikla flakons (plastmasas kastē), 1 deva |
-
|
| V/NRP/00/1234-03 |
|
50 |
Stikla flakons (plastmasas kastē), 1 deva |
-
|
| V/NRP/00/1234-04 |
|
100 |
Stikla flakons (plastmasas kastē), 1 deva |
-
|
| V/NRP/00/1234-05 |
|
1 |
Stikla flakons (kartona kastē), 1 deva |
-
|
| V/NRP/00/1234-06 |
|
10 |
Stikla flakons (kartona kastē), 1 deva |
-
|
| V/NRP/00/1234-07 |
|
50 |
Stikla flakons (kartona kastē), 1 deva |
-
|
| V/NRP/00/1234-08 |
|
100 |
Stikla flakons (kartona kastē), 1 deva |
-
|
|
|
Cefaximin-L
|
-
|
V/NRP/01/1375
|
Fatro S.p.A., Itālija
|
QJ51RD34
|
cows
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Intramammary emulsion
|
| International name (active substance): |
Rifaximin, Cephacetrile sodium
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
04-Jul-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 23022022LI (23-Feb-2022)
|
| Labelling text: |
[DOCX] 23022022M (23-Feb-2022)
|
| Summary of product characteristics: |
[DOCX] 23022022ZA (23-Feb-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1375-01 |
|
4 |
Alumīnija balons, 1 deva |
-
|
|
|
Rifen
|
100 mg/ml
|
V/MRP/10/0005
|
VetViva Richter GmbH , Austrija
|
QM01AE03
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/10/0005-01 |
100 mg/ml |
1 |
Stikla pudelīte (brūna), 50 ml |
-
|
| V/MRP/10/0005-02 |
100 mg/ml |
10 |
Stikla pudelīte (brūna), 100 ml |
-
|
| V/MRP/10/0005-03 |
100 mg/ml |
10 |
Stikla pudelīte (brūna), 50 ml |
-
|
| V/MRP/10/0005-04 |
100 mg/ml |
1 |
Stikla pudelīte (brūna), 100 ml |
-
|
|
|
Animeloxan
|
20 mg/ml
|
V/MRP/19/0057
|
aniMedica GmbH, Vācija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/19/0057-01 |
20 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/MRP/19/0057-02 |
20 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/MRP/19/0057-03 |
20 mg/ml |
12 |
Stikla flakons, 50 ml |
-
|
| V/MRP/19/0057-04 |
20 mg/ml |
12 |
Stikla flakons, 100 ml |
-
|
|
|
Betafuse
|
-
|
V/DCP/16/0028
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QD07CC01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0028-01 |
|
1 |
Alumīnija tūbiņa, 15 g |
-
|
| V/DCP/16/0028-02 |
|
1 |
Alumīnija tūbiņa, 30 g |
-
|
|
|
Vitamin E + Selen vet
|
-
|
V/NRP/05/1523
|
V.M.D. n.v., Beļģija
|
QA11JB
|
cattle (calf); pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/05/1523-01 |
100 mg/ml |
1 |
Flakons, 50 ml |
-
|
| V/NRP/05/1523-02 |
100 mg/ml |
1 |
Flakons, 100 ml |
-
|
|
|
Nobilis Reo 1133
|
-
|
V/NRP/95/0166
|
Intervet International B.V., Nīderlande
|
QI01AD10
|
chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/95/0166-02 |
|
10 |
Stikla flakons, 1000 deva |
-
|
|
|
Hypophysin LA
|
70 µg/ml
|
V/DCP/14/0027
|
Veyx-Pharma GmbH, Vācija
|
QH01BB03
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Carbetocin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
03-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 040719LI (12-Aug-2025)
|
| Labelling text: |
[PDF] 040719M (04-Jul-2019)
|
| Summary of product characteristics: |
[PDF] 040719ZA (04-Jul-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0027-01 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/14/0027-02 |
|
1 |
Stikla flakons, 20 ml |
-
|
| V/DCP/14/0027-03 |
|
1 |
Stikla flakons, 50 ml |
-
|
|
|
Hypophysin LA
|
35 µg/ml
|
V/DCP/14/0026
|
Veyx-Pharma GmbH, Vācija
|
QH01BB03
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Carbetocin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
03-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 040719LI (12-Aug-2025)
|
| Labelling text: |
[PDF] 040719M (04-Jul-2019)
|
| Summary of product characteristics: |
[DOCX] 040719ZA (04-Jul-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0026-01 |
35 µg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/14/0026-02 |
35 µg/ml |
1 |
Stikla flakons, 20 ml |
-
|
| V/DCP/14/0026-03 |
35 µg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/14/0026-05 |
35 µg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Maprelin
|
75 µg/ml
|
V/MRP/09/0015
|
Veyx-Pharma GmbH, Vācija
|
QH01CA
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Peforelin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
03-Oct-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 300913LI (12-Aug-2025)
|
| Labelling text: |
[PDF] 300913M (03-Oct-2013)
|
| Summary of product characteristics: |
[PDF] 300913ZA (03-Oct-2013)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/09/0015-01 |
75 µg/ml |
1 |
Stikla pudelīte, 10 ml |
-
|
| V/MRP/09/0015-02 |
75 µg/ml |
6 |
Stikla pudelīte, 10 ml |
-
|
| V/MRP/09/0015-03 |
75 µg/ml |
1 |
Stikla pudelīte, 50 ml |
-
|
| V/MRP/09/0015-04 |
75 µg/ml |
1 |
Stikla pudelīte, 100 ml |
-
|
|
|
Gonavet Veyx
|
50 µg/ml
|
V/DCP/15/0003
|
Veyx-Pharma GmbH, Vācija
|
QH01CA01
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Gonadorelin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 270215LI (12-Aug-2025)
|
| Labelling text: |
[DOCX] 270215M (28-Apr-2020)
|
| Summary of product characteristics: |
[DOCX] 270215ZA (28-Apr-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0003-01 |
50 µg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/15/0003-02 |
50 µg/ml |
1 |
Stikla flakons, 20 ml |
-
|
| V/DCP/15/0003-03 |
50 µg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Spasmalgan compositum
|
-
|
V/DCP/20/0037
|
Veyx-Pharma GmbH, Vācija
|
QA03DB04
|
cattle; pigs; horses; dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Metamizole sodium monohydrate, Hyoscine butylbromide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 03072020LI (12-Aug-2025)
|
| Labelling text: |
[DOCX] 03072020M (03-Jul-2020)
|
| Summary of product characteristics: |
[DOCX] 26012022ZA (26-Jan-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0037-01 |
500 mg/4 ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/20/0037-02 |
500 mg/4 ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Sensiblex
|
40 mg/ml
|
V/DCP/17/0026
|
Veyx-Pharma GmbH, Vācija
|
QG02CX90
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Denaverine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
27-Jul-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 27072022LI (12-Aug-2025)
|
| Labelling text: |
[DOCX] 27072022M (27-Jul-2022)
|
| Summary of product characteristics: |
[DOCX] 27092022ZA (27-Sep-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0026-01 |
40 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/17/0026-02 |
40 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Vetospirin
|
1000 mg/g
|
V/DCP/19/0061
|
V.M.D. n.v., Beļģija
|
QN02BA04
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0061-01 |
|
10 |
Polietilēna maisiņš, 100 g |
-
|
| V/DCP/19/0061-02 |
|
1 |
Polietilēna maisiņš, 1 kg |
-
|
| V/DCP/19/0061-03 |
|
1 |
Polietilēna maisiņš, 5 kg |
-
|
|
|
INTRAMAR Lacto 200 mg + 50 mg + 10 mg
|
-
|
V/DCP/25/0006
|
Bioveta a.s., Čehija
|
QJ51RV01
|
cattle (lactating cows)
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0006-01 |
|
24 |
Injektors, 4,5 ml |
-
|
| V/DCP/25/0006-02 |
|
24 |
Injektors (un dezinfekcijas salvetes), 4,5 ml |
-
|
|